Effect [qlco]
Oestradiol valerate [horm, phsu, strd]
dienogest [horm, phsu, strd]
Combination [qlco]
Serum [bdsu]
homocysteine levels [lbpr]
postmenopausal [tmco]
Women [popg]
Clinical Trial [resa]
Several [qnco]
studies [lbpr]
Verified [ftcn]
Hormone replacement therapy [topp]
effects [qlco]
postmenopausal [tmco]
Women [popg]
CARDIOVASCULAR [bdsy]
condition [dsyn]
Highly significant [qlco]
Recent [tmco]
studies [lbpr]
Reported [inpr]
Women [popg]
treated [topp]
Hormone replacement therapy [topp]
More [ftcn]
cardiovascular events [fndg]
untreated [fndg]
Women [popg]
Elevated [qlco]
homocysteine level [lbpr]
One [qnco]
Risk factor [qnco]
Cardiovascular disease [dsyn]
Good [qlco]
indicator [irda]
Cardiovascular disease [dsyn]
Risk [qlco]
Examined [fndg]
Plasma homocystine level [lbpr]
postmenopausal [tmco]
Women [popg]
treated [topp]
Hormone replacement therapy [topp]
Study [mnob]
Administered [ftcn]
Oestradiol valerate [horm, phsu, strd]
mg% [qnco]
mg% [qnco]
postmenopausal [tmco]
Women [popg]
Menopause [phsf]
Clinic [hcro, mnob]
Measured [qlco]
Plasma homocystine level [lbpr]
Patients [podg]
baseline [bodm]
months [tmco]
therapy [ftcn]
Plasma homocystine level [lbpr]
treated [topp]
Patients [podg]
Not significant [fndg]
Statistically [ocdi]
P NOS [aapp, imft]
Result [ftcn]
months [tmco]
Oestradiol valerate [horm, phsu, strd]
therapy [ftcn]
Not [ftcn]
Change [ftcn]
homocysteine levels [lbpr]
postmenopausal [tmco]
Women [popg]
